These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26379781)

  • 1. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.
    Hara M; Inoue I; Yamazaki Y; Kirita A; Matsuura T; Friedman SL; Rifkin DB; Kojima S
    Fibrogenesis Tissue Repair; 2015; 8():17. PubMed ID: 26379781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis.
    Hara M; Kirita A; Kondo W; Matsuura T; Nagatsuma K; Dohmae N; Ogawa S; Imajoh-Ohmi S; Friedman SL; Rifkin DB; Kojima S
    Springerplus; 2014; 3():221. PubMed ID: 24877031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease.
    Yokoyama H; Masaki T; Inoue I; Nakamura M; Mezaki Y; Saeki C; Oikawa T; Saruta M; Takahashi H; Ikegami M; Hano H; Ikejima K; Kojima S; Matsuura T
    Heliyon; 2019 Feb; 5(2):e01231. PubMed ID: 30815603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute liver injury by suppressing plasma kallikrein-dependent activation of latent TGF-β.
    Li M; Qin XY; Furutani Y; Inoue I; Sekihara S; Kagechika H; Kojima S
    Biochem Biophys Res Commun; 2018 Oct; 504(4):857-864. PubMed ID: 30219233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency-associated Peptide Degradation Fragments Produced in Stellate Cells and Phagocytosed by Macrophages in Bile Duct-ligated Mouse Liver.
    Inoue I; Qin XY; Masaki T; Mezaki Y; Matsuura T; Kojima S; Furutani Y
    J Histochem Cytochem; 2021 Nov; 69(11):723-730. PubMed ID: 34674567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
    Pedersen RS; Nissen NI; Jensen C; Thorlacius-Ussing J; Manon-Jensen T; Olesen ML; Langholm LL; Diab HMH; Jorgensen LN; Hansen CP; Chen IM; Johansen JS; Karsdal MA; Willumsen N
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
    Sakata K; Eda S; Lee ES; Hara M; Imoto M; Kojima S
    Biochem Biophys Res Commun; 2014 Jan; 443(3):950-6. PubMed ID: 24361885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
    Roth-Eichhorn S; Kühl K; Gressner AM
    Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
    BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
    Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
    Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.
    Dooley S; Delvoux B; Lahme B; Mangasser-Stephan K; Gressner AM
    Hepatology; 2000 May; 31(5):1094-106. PubMed ID: 10796885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells.
    Mehta KJ; Coombes JD; Briones-Orta M; Manka PP; Williams R; Patel VB; Syn WK
    Am J Med Sci; 2018 Feb; 355(2):183-190. PubMed ID: 29406047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
    Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
    Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
    Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
    Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo.
    Okuno M; Sato T; Kitamoto T; Imai S; Kawada N; Suzuki Y; Yoshimura H; Moriwaki H; Onuki K; Masushige S; Muto Y; Friedman SL; Kato S; Kojima S
    J Hepatol; 1999 Jun; 30(6):1073-80. PubMed ID: 10406186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.